RGC

Regencell Bioscience Holdings
D

RGC

4.17000
USD
-0.19
(-4.36%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
3,139
الربح لكل سهم
0
العائد الربحي
-
P/E
-176
حجم السوق
2,067,837,848
أصول ذات صلة

العنوان: Regencell Bioscience Holdings Limited

القطاع: الرعاية الصحية
الصناعة: Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.

أسئلة شائعة حول سهم Regencell Bioscience Holdings